Skip to the ledger

GrantClerk

NSF award 2624615 · University of Maryland, College Park

Collaborative Research: Engineering spatiotemporal temperature control of solvated noble-metal nanoparticles through the understanding of solid-water nanoscale conduction

Final report due

28 August 2028

in 680 days · The award ends on 30 April 2028.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

  • Decide about an extension1 Jan 2028in 440 days

    award ending 2028-04-30 · Research.gov

  • Extension request16 Mar 2028in 515 days

    award ending 2028-04-30 · Research.gov

  • No-cost extension notice20 Apr 2028in 550 days

    award ending 2028-04-30 · Research.gov

  • Final report due28 Aug 2028in 680 days

    award ending 2028-04-30 · Research.gov

  • Project outcomes report due28 Aug 2028in 680 days

    award ending 2028-04-30 · Research.gov

  • Award is closed out28 Aug 2028in 680 days

    award ending 2028-04-30 · Research.gov

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

  1. NSF lists this award's end date as 30 April 2028.
  2. NSF rules say the final report is due no later than 120 days after that.
  3. So the final report is due by 28 August 2028.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number
2624615
Period of support
15 Apr 2026 – 30 Apr 2028
Amount
$174,936
Awardee
University of Maryland, College Park, College Park, MD
Program
TTP-Thermal Transport Process
Directorate
ENG

Abstract

The use of light-activated gold nanoparticles for thermal ablation of cancerous tissue and localized thermally-activated drug and gene delivery systems has been extensively investigated. However, these therapeutic approaches have stalled at the preclinical stage because the nanoparticle temperature cannot be controlled precisely, which leads to effects on tissue away from the therapeutic target. The conversion of…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.